Deep learning-based breast MRI for predicting axillary lymph node metastasis: a systematic review and meta-analysis
- PMID: 40165212
- PMCID: PMC11956454
- DOI: 10.1186/s40644-025-00863-3
Deep learning-based breast MRI for predicting axillary lymph node metastasis: a systematic review and meta-analysis
Abstract
Background: To perform a systematic review and meta-analysis that assesses the diagnostic performance of deep learning algorithms applied to breast MRI for predicting axillary lymph nodes metastases in patients of breast cancer.
Methods: A systematic literature search in PubMed, MEDLINE, and Embase databases for articles published from January 2004 to February 2025. Inclusion criteria were: patients with breast cancer; deep learning using MRI images was applied to predict axillary lymph nodes metastases; sufficient data were present; original research articles. Quality Assessment of Diagnostic Accuracy Studies-AI and Checklist for Artificial Intelligence in Medical Imaging was used to assess the quality. Statistical analysis included pooling of diagnostic accuracy and investigating between-study heterogeneity. A summary receiver operating characteristic curve (SROC) was performed. R statistical software (version 4.4.0) was used for statistical analyses.
Results: A total of 10 studies were included. The pooled sensitivity and specificity were 0.76 (95% CI, 0.67-0.83) and 0.81 (95% CI, 0.74-0.87), respectively, with both measures having moderate between-study heterogeneity (I2 = 61% and 60%, respectively; p < 0.01). The SROC analysis yielded a weighted AUC of 0.788.
Conclusion: This meta-analysis demonstrates that deep learning algorithms applied to breast MRI offer promising diagnostic performance for predicting axillary lymph node metastases in breast cancer patients. Incorporating deep learning into clinical practice may enhance decision-making by providing a non-invasive method to more accurately predict lymph node involvement, potentially reducing unnecessary surgeries.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Sedeta ET, Jobre B, Avezbakiyev B. Breast cancer: global patterns of incidence, mortality, and trends. J Clin Oncol. 2023;41(16_suppl):10528-.
-
- Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol. 1997;66(1):2–6. - PubMed
-
- Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188(1):49–61. - PubMed
-
- Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–26. - PMC - PubMed
-
- Krag D, Harlow S, Julian T. Breast cancer and the NSABP-B32 sentinel node trial. Breast Cancer. 2004;11(3):221–4 discussion 64–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
